DexCom, Inc.: Dexcom rtCGM is Likely to be Cost-Saving, Stud

For people with diabetes treated with insulin, Dexcom rtCGM is associated with significant improvements over patients' lifetimes and is likely to be cost-saving to the NHS DexCom, Inc. (NASDAQ:DXCM)

Related Keywords

United Kingdom , France , San Diego , California , United States , Ben Byrne , Dexcom Inc , Nasdaq , Association Of Continuous Glucose Monitoring With Glycemic , National Health Service , Blood Glucose , Insulin Therapy , United Kingdom Ireland , Dexcom Clarity , Dexcom Follow , Dexcom One , Dexcom Share , Patients With Type , Dexcom , Nexcom , Rtcgm , Likely , Most , Caving , Study , Uggests ,